Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses
/in Breast Cancer, International Publications /von 2006-04-01 / Clin. Exp. Immunol. 2006 Apr;144(1):41-7Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses
/in International Publications, Malignant Pleural Mesothelioma /von 2006-03-15 / Eur. Respir. J. 2006 Jun;27(6):1086-95Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation
/in Chronic Leukemia, International Publications /von 2006-03-09 / Leuk. Res. 2006 Jul;30(7):785-94Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin’s lymphoma and multiple myeloma
/in International Publications, Malignant Lymphoma /von 2006-03-07 / Ann. Hematol. 2006 May;85(5):308-14Immunization with heat shock protein 105-pulsed dendritic cells leads to tumor rejection in mice
/in Dendritic Cells, Hyperthermia, International Publications /von 2006-03-03 / Biochem. Biophys. Res. Commun. 2006 Apr;343(1):269-78Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses
/in International Publications, Malignant Melanoma /von 2006-03-01 / Int. J. Oncol. 2006 Mar;28(3):585-93Combined action of virus injection and local tumor irradiation on tumor growth in mice
/in International Publications, Newcastle Disease Virus /von 2006-03-01 / Coll Antropol 2006 Mar;30(1):185-9Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells
/in HIV/AIDS, International Publications /von 2006-02-28 / AIDS 2006 Feb;20(4):627-30Hyperthermia enhances CTL cross-priming
/in Hyperthermia, International Publications /von 2006-02-15 / J. Immunol. 2006 Feb;176(4):2134-41Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA
/in Hepatocellular Carcinoma, International Publications /von 2006-02-10 / Cell. Immunol. 2005 Nov;238(1):61-6Therapeutic cancer vaccines
/in International Publications, Prostate Cancer /von 2006-02-07 / Curr. Opin. Immunol. 2006 Apr;18(2):201-5Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12
/in Glioblastoma, International Publications /von 2006-02-04 / Cancer Immunol. Immunother. 2006 Nov;55(11):1309-19Imatinib mesylate minimally affects bcr-abl+ and normal monocyte-derived dendritic cells but strongly inhibits T cell expansion despite reciprocal dendritic cell-T cell activation
/in Chronic Leukemia, International Publications /von 2006-02-03 / J. Leukoc. Biol. 2006 Apr;79(4):747-56Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost
/in HIV/AIDS, International Publications /von 2006-02-02 / Clin. Immunol. 2006 Apr;119(1):32-7Generation of in vitro B-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotic tumor lysate
/in Chronic Leukemia, International Publications /von 2006-02-01 / Leuk. Lymphoma 2006 Feb;47(2):297-306Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens
/in Chronic Virus Hepatitis, International Publications /von 2006-02-01 / Gastroenterology 2006 Feb;130(2):453-64Novel immunotherapeutic approaches to glioma
/in Glioblastoma, International Publications /von 2006-02-01 / Curr. Opin. Mol. Ther. 2006 Feb;8(1):46-51Recent advances in heat shock protein-based cancer vaccines
/in Hyperthermia, International Publications /von 2006-02-01 / HBPD INT 2006 Feb;5(1):22-7A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes
/in International Publications, Newcastle Disease Virus /von 2006-02-01 / Int. J. Cancer 2006 Feb;118(3):658-67Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
/in Dendritic Cells, International Publications, SCLC /von 2006-02-01 / Clin. Cancer Res. 2006 Feb;12(3 Pt 1):878-87